---
category: news
title: "Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma"
excerpt: "We leverage advances in machine learning, genomics, and artificial intelligence by using a proprietary A.I. platform to discover biomarker signatures that help identify patients more likely to ..."
publishedDateTime: 2020-12-17T12:13:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-announces-collaboration-with-world-leading-brain-cancer-program-at-johns-hopkins-to-further-develop-lp-184-as-therapy-for-glioblastoma-1029901874"
webUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-announces-collaboration-with-world-leading-brain-cancer-program-at-johns-hopkins-to-further-develop-lp-184-as-therapy-for-glioblastoma-1029901874"
type: article

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg"
    width: 400
    height: 296
    isCached: true

secured: "u0iWKAfTcx6hkQRcNc892d0aE7Y+wS8MTFF0g0oIvTcc2MID0hUXmj7KGQvQ5gjOKFCP44kezZk5vy1hBrGo53yL65Hv7y/QcsorGxbnLjaEzxWcdpPad3kGVauvJY+fxk05Uo613GH8acilEfx3WiZn7SRkmTGMuNjd2Qd9xEYiTI7qAYIDAHlE/eYRfnCAbBU5ous8f4VtR9DJoz9yfucMEfW0dvuhRxpW5c122JUaythHXUxDUzsYCqeQe8wr0FtQcVuMGuE8WdGsSUms9S4BbD7MaE9fWSj4NQJgHKYFYp86XbVKwMPx0r0GQwZ65jpbj7WZ2+WJw/7mfkHojwrLUaOmT/u2H+zbfEQZvnQ=;Amuf6/vGT9xQzgyqiiEo6Q=="
---

